参考文献/References:
[1] Song M,Wang H, Song L, et al. Ectopic TSH-secreting pituitary tumor: a case report and review of prior cases[J].BMC Cancer,2014,14:544.DOI:10.1186/1471-2407-14-544.
[2] Amlashi FG, Tritos NA.Thyrotropin-secreting pituitary adenomas:epidemiology, diagnosis, and management [J].Endocrine,2016,52(3):427-440.DOI:10.1007/s12020-016-0863-3.
[3] Jailer JW, Holub DA. Remission of Graves' disease following radiotherapy of a pituitary neoplasm[J].Am J Med,1960,28:497-500.DOI:10.1016/0002-9343(60)90181-9.
[4] 施法兴. 分泌促甲状腺素型垂体肿瘤1例报告[J]. 新医学,1981,12(1):18-19.
[5] 范晓静,臧丽,杜锦,等.对国内153例垂体促甲状腺素腺瘤临床报道的文献复习[J].中华内分泌代谢杂志,2018,34(8):660-666. DOI:10.3760/cma.j. issn.1000 -6699. 2018.08.007.
[6] 宋明强,张静华,田海晔,等. 第412例甲状腺肿—房颤—TSH正常—FT3、FT4升高[J].中华医学杂志, 2017,97(34): 2703-2705.DOI:10.3760/cma.j.isn. 0376-2491. 2017. 34.013.
[7] Cooper DS, Wenig BM.Hyperthyroidism caused by an ectopic TSH-secreting pituitary tumor[J].Thyroid,1996,6(4):337-342.DOI:10.1089/thy.1996.6.337.
[8] Pasquini E, Faustini M, Sciarretta V, et al. Ectopic TSH-secreting pituitary adenoma of the vomerosphenoidal junction[J].Eur J Endocrinol, 2003,148(2):253-257.DOI:10.1530/eje. 0. 1480253.
[9] Collie RB, Collie MJ. Extracranial thyroid-stimulating hormone-secreting ectopic pituitary adenoma of the nasopharynx[J].Otolaryngol Head Neck Surg, 2005,133(3):453-454.DOI:10.1016/j.otohns.2004.10.015.
[10] 宋明强,张允明,徐翠兰,等.异位促甲状腺激素分泌瘤一例[J].中华内分泌外科杂志,2013, 7(3):258-260. DOI:10.3760/cma.j.issn.1674-6090.2016.04.023.
[11] Tong A, Xia W, Qi F, et al.Hyperthyroidism caused by an ectopic thyrotropin-secreting tumor of the nasopharynx:a case report and review of the literature[J].Thyroid,2013,23(9):1172-1177.DOI:10.1089/thy.2012.0574.
[12] Nishiike S, Tatsumi KI, Shikina T, et al. Thyroid-stimulating hormone-secreting ectopic pituitary adenoma of the nasopharynx[J].Auris Nasus Larynx, 2014,41(6):586-588.DOI:org/10.1016/j.anl.2014.07.004.
[13] Wang Q, Lu X,Sun J, et al. Ectopic suprasellar thyrotropin-secreting pituitary adenoma:case report and literature review[J].World Neurosurg,2016,95:617.e13-e617.e18.DOI:org /10.1016/j.wneu.2016.08.062.
[14] Yang J, Liu S, Yang Z, et al.Ectopic thyrotropin secreting pituitary adenoma concomitant with papillary thyroid carcinoma[J].Medicine, 2017,96:50(e8912).DOI: org/10.1097 /MD. 0000000000008912.
[15] Refetoff S, DeWind LT, DeGroot LJ. Familial syndrome combining deaf-mutism,stippled epiphyses, goiter and abnormally high PBI:possible target organ refractoriness to thyroid hormone[J].J Clin Endocrinol Metab,1967,27(2):279-294.DOI:10.1210/jcem-27-2-279.
[16] Pohlenz J,Weiss RE, Macchia PE,et al. Five new families with resistance to thyroid hormone not caused by mutations in the thyroid hormone receptor beta gene[J].J Clin Endocrinol Metab,1999,84:3919-3928.DOI:10.1210/jcem.84.11.6080.
[17] Tajima T, Jo W, Fujikura K, et al. Elevated free thyroxine levels detected by a neonatal secreening system[J].Pediatr Res,2009,66(3):312-316.DOI:10.1203/PDR. 0b013e3181b1 bcbd.
[18] 刘永宁,魏强,边艳珠,等.选择性垂体甲状腺激素抵抗综合征二例[J].中华内科杂志,2006,45(4):327-327.DOI:10.3760/j.issn.0578-1426.2006.04.027.
[19] Savovska M, Stojanoski S, Manevska N. A rare case of partial peripheral thyroid hormone resistance due to a point mutation in the membrane integrin Α(Ⅴ)Β(3)and concomitant Hashimoto's thyroiditis[J].Open Access Maced J Med Sci, 2019,7(12):1991-1997.DOI:10.3889/oamjms.2019.582.
[20] Teng X, Jin T, Gregory A.Brent, et al. A patient with a thyrotropin-secreting micro-adenoma and resistance to thyroid hormone(P453T)[J].J Clin Endocrinol Metab,2015,100(7):2511-2514.DOI:10.1210/jc.2014-3994.
[21] Patricia Mjønes,Liv Sagatun,Ivar S. Nordrum,et al. Neuron-specific enolase as an immunohistochemical marker is better than its reputation[J].J Histochem Cytochem,2017,65(12):687-703.DOI:10.1369/0022155417733676.
[22] 叶蕾,韩如来,姜晓华,等.促甲状腺激素不适当分泌综合征61例病例总结[J].中华内分泌代谢杂志,2015,31(11):925-931.DOI:10.3760/cma. j.issn.1000-6699.2015.11. 001.
[23] 中国垂体腺瘤协作组.中国垂体促甲状腺激素腺瘤诊治专家共识(2017)[J].中华医学杂志,2017, 97(15):1128-1131.DOI:10.3760/cma.j.issn.0376-2491.2017.15.004.
[24] 姜晓华,蔡洁,王卫庆,等.垂体促甲状腺素瘤的临床特点与诊治分析[J].中华内分泌代谢杂志,2012,28(9):729-733.DOI:10.3760/cma.j.issn.1000-6699.2012.09.009.
[25] Yu B,Zhang Z,Song H, et al.Clinical importance of somatostatin receptor 2(SSTR2)and somatostatin receptor 5(SSTR5)expression in thyrotropin-producing pituitary adenoma(TSHoma)[J].Med Sci Monit,2017,23:1947-1955.DOI:10.12659/MSM.903377.
[26] Terzolo M, Oriandi F,Bassetti M,et al. Hyperthyroidism due to a pituitary adenoma composed of two different cell type, one secreting alpha-subunit alone and another cosecreting alpha-subunit and thyrotropin[J].J Clin Endocrinol Metab,1991,72(2):415-421.DOI:10.1210/jcem-72-2-415.
[27] Beck-Peccoz P,Persani L,Mannavola D,et al.Pituitary tumours: TSH-secreting adenomas[J].Best Pract Res Clin Endocrinol Metab,2009,23(5):597-606.DOI:10.1016/j.beem.2009.05.006.
[28] Beck-Peccoz P, Lania A, Beckers A, et al. 2013 European thyroid association guidelines for the diagnosis and treatment of thyrotropin secreting pituitary tumors[J].Eur Thyroid J, 2013,2(2):76-82.DOI:10.1159/000351007.